US5112824A
(en)
|
1989-12-08 |
1992-05-12 |
Merck & Co., Inc. |
Benzofuran compounds as class III antiarrhythmic agents
|
FR2665159B1
(fr)
|
1990-07-24 |
1992-11-13 |
Rhone Poulenc Sante |
Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
DE4212748A1
(de)
|
1992-04-16 |
1993-10-21 |
Thomae Gmbh Dr K |
Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
GB9420521D0
(en)
|
1994-10-12 |
1994-11-30 |
Smithkline Beecham Plc |
Novel compounds
|
GB9420999D0
(en)
|
1994-10-18 |
1994-12-07 |
Smithkline Beecham Plc |
Novel compounds
|
AU4515896A
(en)
|
1994-12-12 |
1996-07-03 |
Merck & Co., Inc. |
Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
|
GB9500580D0
(en)
|
1995-01-12 |
1995-03-01 |
Merck Sharp & Dohme |
Therapeutic agents
|
CN1151147C
(zh)
|
1995-02-02 |
2004-05-26 |
史密丝克莱恩比彻姆有限公司 |
作为5-ht受体拮抗剂的吲哚衍生物
|
US5668148A
(en)
|
1995-04-20 |
1997-09-16 |
Merck & Co., Inc. |
Alpha1a adrenergic receptor antagonists
|
GB9517559D0
(en)
|
1995-08-26 |
1995-10-25 |
Smithkline Beecham Plc |
Novel compounds
|
US5886186A
(en)
|
1995-10-25 |
1999-03-23 |
Versicor, Inc. |
Synthesis of substituted N-heteroaromatic compounds and methods of use thereof
|
JP2000507590A
(ja)
|
1996-04-03 |
2000-06-20 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシル―タンパク質トランスフェラーゼ阻害剤
|
US5872136A
(en)
|
1996-04-03 |
1999-02-16 |
Merck & Co., Inc. |
Arylheteroaryl inhibitors of farnesyl-protein transferase
|
FR2763944B1
(fr)
|
1997-06-03 |
2000-12-15 |
Centre Nat Rech Scient |
Nouveaux derives de coumarines, leurs procedes de preparation et leur application comme medicaments en tant qu'inhibiteurs de proteases
|
JPH1149676A
(ja)
|
1997-07-31 |
1999-02-23 |
Geron Corp |
ピリジン系テロメラーゼ阻害剤
|
JPH11209366A
(ja)
|
1998-01-23 |
1999-08-03 |
Nissan Chem Ind Ltd |
クロマン誘導体及び心不全治療薬
|
DE69919707T2
(de)
|
1998-06-19 |
2005-09-01 |
Chiron Corp., Emeryville |
Glycogen synthase kinase 3 inhibitoren
|
AR019190A1
(es)
|
1998-07-08 |
2001-12-26 |
Sod Conseils Rech Applic |
Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
|
CA2367340A1
(en)
|
1999-03-16 |
2000-09-21 |
Cytovia, Inc. |
Substituted 2-aminobenzamide caspase inhibitors and the use thereof
|
GB9922171D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
BRPI0113286B8
(pt)
|
2000-08-14 |
2021-05-25 |
Johnson & Johnson |
pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
|
DE60136546D1
(de)
|
2000-09-06 |
2008-12-24 |
Ortho Mcneil Pharm Inc |
Methode zum bekämpfen der allergien durch verwendung von substituierten pyrazolen
|
AU2001292276A1
(en)
|
2000-09-27 |
2002-04-08 |
Toray Industries, Inc. |
Nitrogen-containing compounds and ccr3 inhibitors containing the same as the active ingredient
|
HN2001000224A
(es)
|
2000-10-19 |
2002-06-13 |
Pfizer |
Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
|
US6710058B2
(en)
|
2000-11-06 |
2004-03-23 |
Bristol-Myers Squibb Pharma Company |
Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
|
AU3950802A
(en)
|
2000-12-07 |
2002-06-18 |
Cv Therapeutics Inc |
Abca-1 elevating compounds
|
WO2002053160A1
(en)
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Method for treating glaucoma ivb
|
RU2319701C2
(ru)
|
2001-02-21 |
2008-03-20 |
Астразенека Аб |
ГЕТЕРОПОЛИЦИКЛИЧЕСКОЕ СОЕДИНЕНИЕ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ МЕТАБОТРОПНЫХ ГЛЮТАМАТНЫХ РЕЦЕПТОРОВ mGluR ГРУППЫ I
|
EP1408986B1
(en)
|
2001-05-08 |
2008-09-24 |
Yale University |
Proteomimetic compounds and methods
|
WO2003042190A1
(en)
|
2001-11-12 |
2003-05-22 |
Pfizer Products Inc. |
N-alkyl-adamantyl derivatives as p2x7-receptor antagonists
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
JP2003192673A
(ja)
|
2001-12-27 |
2003-07-09 |
Bayer Ag |
ピペラジンカルボキシアミド誘導体
|
WO2003062224A1
(en)
|
2002-01-17 |
2003-07-31 |
Eli Lilly And Company |
Aza-cyclic compounds as modulators of acetylcholine receptors
|
JP4167848B2
(ja)
|
2002-04-10 |
2008-10-22 |
広栄化学工業株式会社 |
ビアリール化合物の製造法
|
CN1181065C
(zh)
|
2002-05-08 |
2004-12-22 |
上海医药工业研究院 |
芳烷甲酰烷基哌嗪衍生物及其作为脑神经保护剂的应用
|
US20040082627A1
(en)
|
2002-06-21 |
2004-04-29 |
Darrow James W. |
Certain aromatic monocycles as kinase modulators
|
US7015227B2
(en)
|
2002-06-21 |
2006-03-21 |
Cgi Pharmaceuticals, Inc. |
Certain amino-substituted monocycles as kinase modulators
|
JP4741948B2
(ja)
|
2002-08-14 |
2011-08-10 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼインヒビターおよびそれらの使用
|
US7632858B2
(en)
|
2002-11-15 |
2009-12-15 |
Bristol-Myers Squibb Company |
Open chain prolyl urea-related modulators of androgen receptor function
|
CA2515544A1
(en)
|
2003-02-11 |
2004-08-26 |
Kemia Inc. |
Compounds for the treatment of viral infection
|
CL2004000234A1
(es)
|
2003-02-12 |
2005-04-15 |
Biogen Idec Inc |
Compuestos derivados 3-(piridin-2-il)-4-heteroaril-pirazol sustituidos, antagonistas de aik5 y/o aik4; composicion farmaceutica y uso del compuesto en el tratamiento de desordenes fibroticos como esclerodermia, lupus nefritico, cicatrizacion de herid
|
EP2080757A1
(en)
|
2003-07-24 |
2009-07-22 |
Euro-Celtique S.A. |
Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
|
TWI287567B
(en)
|
2003-07-30 |
2007-10-01 |
Chi Mei Optoelectronics Corp |
Light-emitting element and iridium complex
|
EP1651638A1
(en)
|
2003-08-08 |
2006-05-03 |
Janssen Pharmaceutica N.V. |
Pyridyl piperazinyl ureas
|
WO2005016862A1
(en)
|
2003-08-14 |
2005-02-24 |
Asahi Kasei Pharma Corporation |
Substituted arylalkanoic acid derivative and use thereof
|
US7504401B2
(en)
|
2003-08-29 |
2009-03-17 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
EP1663953A1
(en)
|
2003-09-24 |
2006-06-07 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
JP2007524682A
(ja)
|
2004-02-12 |
2007-08-30 |
メルク エンド カムパニー インコーポレーテッド |
代謝調節型グルタミン酸受容体−5の調節物質としてのビピリジルアミド
|
BRPI0508230A
(pt)
|
2004-03-30 |
2007-07-17 |
Chiron Corp |
derivados de tiofeno substituìdo como agentes anti-cáncer
|
ATE454372T1
(de)
|
2004-04-01 |
2010-01-15 |
Lilly Co Eli |
Am histamin-h3-rezeptor wirksame mittel, herstellung und therapeutische anwendungen
|
US7459562B2
(en)
|
2004-04-23 |
2008-12-02 |
Bristol-Myers Squibb Company |
Monocyclic heterocycles as kinase inhibitors
|
FR2869904B1
(fr)
|
2004-05-07 |
2006-07-28 |
Fournier S A Sa Lab |
Modulateurs des recepteurs lxr
|
ATE432926T1
(de)
|
2004-07-26 |
2009-06-15 |
Lilly Co Eli |
Oxazolderivate als histamin-h3-rezeptor- wirkstoffe, deren herstellung und therapeutische verwendung
|
JP2008516989A
(ja)
|
2004-10-19 |
2008-05-22 |
コンパス ファーマシューティカルズ リミティド ライアビリティ カンパニー |
組成物及び抗腫瘍剤としてのその使用
|
CA2585490A1
(en)
|
2004-11-12 |
2006-05-18 |
Galapagos Nv |
Nitrogen heteroaromatic compounds which bind to the active site of protein kinase enzymes
|
CA2588389A1
(en)
|
2004-11-23 |
2006-06-22 |
Ptc Therapeutics, Inc. |
Substituted phenols as active agents inhibiting vegf production
|
CA2589773A1
(en)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Pyridine carboxamide derivatives for use as anticancer agents
|
WO2006067445A2
(en)
|
2004-12-22 |
2006-06-29 |
Astrazeneca Ab |
Csf-1r kinase inhibitors
|
EP2354126B1
(en)
|
2005-01-14 |
2013-09-25 |
ChemoCentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
US7622583B2
(en)
|
2005-01-14 |
2009-11-24 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2
|
EP1683796A1
(en)
|
2005-01-24 |
2006-07-26 |
Schering Aktiengesellschaft |
Pyrazolopyridines, their preparation and their medical use
|
JP2008528580A
(ja)
|
2005-01-27 |
2008-07-31 |
アストラゼネカ・アクチエボラーグ |
P2x7受容体の阻害剤である新規二環式芳香族化合物
|
US7888374B2
(en)
|
2005-01-28 |
2011-02-15 |
Abbott Laboratories |
Inhibitors of c-jun N-terminal kinases
|
US20060178388A1
(en)
|
2005-02-04 |
2006-08-10 |
Wrobleski Stephen T |
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
|
US20070135437A1
(en)
|
2005-03-04 |
2007-06-14 |
Alsgen, Inc. |
Modulation of neurodegenerative diseases
|
EP1879881A2
(en)
|
2005-04-14 |
2008-01-23 |
Bristol-Myers Squibb Company |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type i
|
US7682404B2
(en)
|
2005-05-13 |
2010-03-23 |
Ciba Specialty Chemicals Corporation |
Coloring keratin fibers with metal complexes
|
WO2006128172A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating b cell regulated autoimmune disorders
|
WO2006128129A2
(en)
|
2005-05-26 |
2006-11-30 |
Synta Pharmaceuticals Corp. |
Method for treating cancer
|
AU2006252768A1
(en)
|
2005-06-02 |
2006-12-07 |
Bayer Cropscience Ag |
Phenylalkyl substituted heteroaryl devivatives
|
AU2006258101A1
(en)
|
2005-06-09 |
2006-12-21 |
Merck Sharp & Dohme Corp. |
Inhibitors of checkpoint kinases
|
AR053901A1
(es)
|
2005-06-20 |
2007-05-23 |
Astrazeneca Ab |
Formas fisicas de oxabispidinas n,n'- disustituidas
|
ATE455103T1
(de)
|
2005-06-24 |
2010-01-15 |
Bristol Myers Squibb Co |
Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate
|
PE20070099A1
(es)
|
2005-06-30 |
2007-02-06 |
Janssen Pharmaceutica Nv |
N-heteroarilpiperazinil ureas como moduladores de la amida hidrolasa del acido graso
|
WO2007008541A2
(en)
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc. |
Cellular cholesterol absorption modifiers
|
FR2892412B1
(fr)
|
2005-10-26 |
2008-05-16 |
Galderma Res & Dev |
Composes biaromatiques modulateurs des ppars
|
TW200804307A
(en)
|
2005-10-27 |
2008-01-16 |
Synta Pharmaceuticals Corp |
Process for preparing mesylate salts of IL-12 inhibitory compounds
|
WO2007055941A2
(en)
|
2005-11-03 |
2007-05-18 |
Merck & Co., Inc. |
Histone deacetylase inhibitors with aryl-pyrazolyl motifs
|
HUE032640T2
(en)
|
2005-11-08 |
2017-10-30 |
Vertex Pharma |
Heterocyclic modulator of ATP-binding cassette transcripts
|
WO2007055374A1
(ja)
|
2005-11-14 |
2007-05-18 |
Mitsubishi Tanabe Pharma Corporation |
骨粗鬆症治療剤
|
AR057579A1
(es)
|
2005-11-23 |
2007-12-05 |
Merck & Co Inc |
Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
|
AU2006320580B2
(en)
|
2005-11-30 |
2011-06-23 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of c-Met and uses thereof
|
CA2633425A1
(en)
|
2005-12-23 |
2007-06-28 |
F. Hoffmann-La Roche Ag |
Aryl-isoxazolo-4-yl-oxadiazole derivatives
|
JP2009523726A
(ja)
|
2006-01-12 |
2009-06-25 |
メルク エンド カムパニー インコーポレーテッド |
ヒドロキシアルキルアリールアミド誘導体
|
WO2007087129A2
(en)
|
2006-01-12 |
2007-08-02 |
Merck & Co., Inc. |
Fluorinated arylamide derivatives
|
TW200813015A
(en)
|
2006-03-15 |
2008-03-16 |
Mitsubishi Pharma Corp |
2-(cyclic amino)-pyrimidone derivatives
|
JP2007283748A
(ja)
|
2006-03-23 |
2007-11-01 |
Fujifilm Corp |
光記録媒体および可視情報記録方法
|
DK2368550T3
(da)
|
2006-03-27 |
2013-09-30 |
Univ California |
Androgenreceptormodulator til behandlingen af prostatakræft og androgenreceptor-associerede sygdomme
|
ES2452820T3
(es)
|
2006-04-07 |
2014-04-02 |
Methylgene, Inc. |
Derivados de benzamida como inhibidores de histona desacetilasa
|
WO2007125984A1
(ja)
|
2006-04-28 |
2007-11-08 |
Nihon Nohyaku Co., Ltd. |
イソキサゾリン誘導体及び有害生物防除剤並びにその使用方法
|
US20090118336A1
(en)
|
2006-05-03 |
2009-05-07 |
Laurent David |
Pyrazole derivatives and their use as pi3k inhibitors
|
JP2009535386A
(ja)
|
2006-05-03 |
2009-10-01 |
アストラゼネカ アクチボラグ |
チアゾール誘導体および抗腫瘍剤としてのその使用
|
US20080064871A1
(en)
|
2006-05-26 |
2008-03-13 |
Japan Tobacco Inc. |
Production Method of Nitrogen-Containing Fused Ring Compounds
|
DE602007006010D1
(de)
|
2006-05-31 |
2010-06-02 |
Galapagos Nv |
Triazolopyrazinverbindungen zur behandlung von degenerations- und entzündungskrankheiten
|
US20100022547A1
(en)
|
2006-06-02 |
2010-01-28 |
Brandeis University |
Compounds and Methods for Treating Mammalian Gastrointestinal Parasitic Infections
|
US20080280891A1
(en)
|
2006-06-27 |
2008-11-13 |
Locus Pharmaceuticals, Inc. |
Anti-cancer agents and uses thereof
|
WO2008005457A2
(en)
|
2006-06-30 |
2008-01-10 |
Sunesis Pharmaceuticals |
Pyridinonyl pdk1 inhibitors
|
US8519135B2
(en)
|
2006-07-14 |
2013-08-27 |
Chemocentryx, Inc. |
Heteroaryl sulfonamides and CCR2/CCR9
|
US7981874B2
(en)
|
2006-07-20 |
2011-07-19 |
Merck Sharp & Dohme Corp. |
Phosphorus derivatives as histone deacetylase inhibitors
|
GB0614579D0
(en)
|
2006-07-21 |
2006-08-30 |
Black James Foundation |
Pyrimidine derivatives
|
EP2057124A2
(en)
|
2006-07-21 |
2009-05-13 |
Irm, Llc |
Compounds and compositions as itpkb inhibitors
|
FR2903985B1
(fr)
|
2006-07-24 |
2008-09-05 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
|
WO2008013963A2
(en)
|
2006-07-28 |
2008-01-31 |
University Of Connecticut |
Fatty acid amide hydrolase inhibitors
|
WO2008016643A2
(en)
|
2006-08-01 |
2008-02-07 |
Cytokinetics, Incorporated |
Certain chemical entities, compositions, and methods
|
WO2008024978A2
(en)
|
2006-08-24 |
2008-02-28 |
Serenex, Inc. |
Tetrahydroindolone and tetrahydroindazolone derivatives
|
US20080076813A1
(en)
|
2006-08-24 |
2008-03-27 |
Huang Kenneth H |
Benzene, Pyridine, and Pyridazine Derivatives
|
EP2066676A1
(en)
|
2006-09-18 |
2009-06-10 |
Vertex Pharmaceuticals, Inc. |
HETEROCYCLIC INHIBITORS OF c-MET AND USES THEREOF
|
DK2076508T3
(da)
|
2006-10-18 |
2011-02-21 |
Pfizer Prod Inc |
Biaryl-ether-urinstof-forbindelser
|
DE102006050515A1
(de)
|
2006-10-26 |
2008-04-30 |
Bayer Healthcare Ag |
Substituierte Dipyridiyl-dihydropyrazolone und ihre Verwendung
|
US7858645B2
(en)
|
2006-11-01 |
2010-12-28 |
Hoffmann-La Roche Inc. |
Indazole derivatives
|
WO2008053913A1
(fr)
|
2006-11-02 |
2008-05-08 |
Shionogi & Co., Ltd. |
Dérivé de sulfonylurée capable d'inhiber sélectivement mmp-13
|
JP2009023986A
(ja)
|
2006-11-08 |
2009-02-05 |
Pharma Ip |
抗癌剤としてのビアリール誘導体
|
US20080145816A1
(en)
|
2006-12-15 |
2008-06-19 |
Hershey Adrienne A |
Yankauer suction device
|
DK2125822T3
(en)
|
2006-12-21 |
2015-01-12 |
Nerviano Medical Sciences Srl |
SUBSTITUTED PYRAZOLOQUINAZOLINDERIVATER, process for their preparation and their use as kinase inhibitors
|
FR2910473B1
(fr)
|
2006-12-26 |
2009-02-13 |
Sanofi Aventis Sa |
Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
|
AR064660A1
(es)
|
2006-12-26 |
2009-04-15 |
Mitsubishi Tanabe Pharma Corp |
Derivados de pirimidinona 6-heterociclica 2-sustituida, medicamentos que los contienen y usos para prevenir y/o tratar enfermedades neurodegenerativas entre otras
|
JP2008179068A
(ja)
|
2007-01-25 |
2008-08-07 |
Fujifilm Corp |
光記録媒体および可視情報記録方法
|
JP2008179067A
(ja)
|
2007-01-25 |
2008-08-07 |
Fujifilm Corp |
光記録媒体および可視情報記録方法
|
ES2702362T3
(es)
|
2007-01-31 |
2019-02-28 |
Ym Biosciences Australia Pty |
Compuestos a base de tiopirimidina y usos de los mismos
|
MX2009009936A
(es)
|
2007-03-20 |
2010-02-11 |
Curis Inc |
Amino piridina fusionada como inhibidores de hsp90.
|
WO2008115262A2
(en)
|
2007-03-20 |
2008-09-25 |
Curis, Inc. |
Hsp90 inhibitors containing a zinc binding moiety
|
US8461343B2
(en)
|
2007-03-27 |
2013-06-11 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of thiohydantoins
|
FR2915198B1
(fr)
|
2007-04-18 |
2009-12-18 |
Sanofi Aventis |
Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
|
US20100120839A1
(en)
|
2007-04-20 |
2010-05-13 |
Biolipox Ab |
Pyrazoles useful in the treatment of inflammation
|
WO2008139152A1
(en)
|
2007-05-11 |
2008-11-20 |
Sentinel Oncology Limited |
N-oxide-containing pharmaceutical compounds
|
MX2009013169A
(es)
|
2007-06-03 |
2010-04-30 |
Univ Vanderbilt |
Moduladores alostericos positivos del mglur5 benzamida y metodos de elaboracion y uso de los mismos.
|
NZ581610A
(en)
|
2007-06-05 |
2012-02-24 |
Sanofi Aventis |
Substituted benzoylamino-indan-2-carboxylic acids and related compounds
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
CN101808518A
(zh)
|
2007-06-27 |
2010-08-18 |
默沙东公司 |
作为组蛋白脱乙酰酶抑制剂的吡啶基和嘧啶基衍生物
|
WO2009022171A1
(en)
|
2007-08-13 |
2009-02-19 |
Astrazeneca Ab |
Pyridinyiioxy pyridines as alk5 inhibitors
|
ES2535166T3
(es)
|
2007-09-04 |
2015-05-06 |
The Scripps Research Institute |
Pirimidinil-aminas sustituidas como inhibidores de proteína-quinasas
|
US8354383B2
(en)
|
2007-09-17 |
2013-01-15 |
Enanta Pharmaceuticals, Inc. |
6,11-bridged biaryl macrolides
|
WO2009037001A2
(en)
|
2007-09-19 |
2009-03-26 |
4Sc Ag |
Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
|
JP5469604B2
(ja)
|
2007-09-19 |
2014-04-16 |
4エスツェー アクチェンゲゼルシャフト |
新規テトラヒドロ融合ピリジン
|
CA2702946A1
(en)
|
2007-10-16 |
2009-04-23 |
Northeastern University |
Monoacylglycerol lipase inhibitors for modulation of cannabinoid activity
|
US20090156825A1
(en)
|
2007-11-26 |
2009-06-18 |
Heidebrecht Jr Richard W |
Fluorescent compounds that bind to histone deacetylase
|
WO2009078992A1
(en)
|
2007-12-17 |
2009-06-25 |
Amgen Inc. |
Linear tricyclic compounds as p38 kinase inhibitors
|
FR2926553B1
(fr)
|
2008-01-23 |
2010-02-19 |
Sanofi Aventis |
Derives d'indole-2-carboxamides et d'azaindole-2- carboxamides substitues par un groupe silanyle, leur preparation et leur application en therapeutique
|
US20110098267A1
(en)
|
2008-02-07 |
2011-04-28 |
Synta Pharmaceuticals Corporation |
Topical formulations for the treatment of psoriasis
|
JP2009209090A
(ja)
|
2008-03-04 |
2009-09-17 |
Mitsui Chemicals Inc |
殺虫剤及び該殺虫剤に含まれる化合物、並びに該化合物の使用方法
|
CL2009000600A1
(es)
|
2008-03-20 |
2010-05-07 |
Bayer Cropscience Ag |
Uso de compuestos de diaminopirimidina como agentes fitosanitarios; compuestos de diaminopirimidina; su procedimiento de preparacion; agente que los contiene; procedimiento para la preparacion de dicho agente; y procedimiento para combatir plagas de animales y/u hongos dañinos patogenos de plantas.
|
WO2009143018A2
(en)
|
2008-05-19 |
2009-11-26 |
Plexxikon, Inc. |
Compounds and methods for kinase modulation, and indications therefor
|
PE20091846A1
(es)
|
2008-05-19 |
2009-12-16 |
Plexxikon Inc |
DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
|
WO2009152083A1
(en)
|
2008-06-10 |
2009-12-17 |
Plexxikon, Inc. |
5h-pyrr0l0 [2,3-b] pyrazine derivatives for kinase modulation, and indications therefor
|
WO2009152087A1
(en)
|
2008-06-10 |
2009-12-17 |
Plexxikon, Inc. |
Bicyclic heteroaryl compounds and methods for kinase modulation, and indications therefor
|
MX2010013876A
(es)
|
2008-06-20 |
2011-03-04 |
Metabolex Inc |
Agonistas de arilo grpr119 y sus usos .
|
MX2010014572A
(es)
|
2008-06-27 |
2011-03-24 |
Novartis Ag |
Compuestos organicos.
|
JP5309216B2
(ja)
|
2008-07-11 |
2013-10-09 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Gpr119活性のモジュレーターとしての4−フェノキシメチルピペリジン類
|
TW201028381A
(en)
|
2008-07-14 |
2010-08-01 |
Shionogi & Co |
Pyridine derivative having ttk inhibition activity
|
KR20110028661A
(ko)
|
2008-07-15 |
2011-03-21 |
노파르티스 아게 |
Dgat1 억제제로서의 헤테로아릴 유도체
|
US8722686B2
(en)
|
2008-09-19 |
2014-05-13 |
Pfizer Inc. |
Hydroxamic acid derivatives useful as antibacterial agents
|
BRPI0920608A2
(pt)
|
2008-09-29 |
2019-09-24 |
Boehringer Ingelheim Int |
compostos quimicos
|
WO2010046780A2
(en)
|
2008-10-22 |
2010-04-29 |
Institut Pasteur Korea |
Anti viral compounds
|
WO2010068863A2
(en)
|
2008-12-12 |
2010-06-17 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimidine compounds and methods of making and using same
|
RU2505540C2
(ru)
|
2008-12-23 |
2014-01-27 |
Эббви Инк. |
Антивирусные соединения
|
WO2010088574A1
(en)
|
2009-01-30 |
2010-08-05 |
Sirtris Pharmaceuticals, Inc. |
Azabenzimidazoles and related analogs as sirtuin modulators
|
WO2010111527A1
(en)
|
2009-03-26 |
2010-09-30 |
Plexxikon, Inc. |
Pyrazolo [ 3, 4 -b] pyridines as kinase inhibitors and their medical use
|
EP2417125B1
(en)
|
2009-03-27 |
2015-09-09 |
Nerviano Medical Sciences S.r.l. |
N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
|
EP2414366A1
(en)
|
2009-04-01 |
2012-02-08 |
Novartis AG |
Spiro derivatives for the modulation of stearoyl-coa desaturase
|
AR076753A1
(es)
|
2009-05-07 |
2011-07-06 |
Gruenenthal Chemie |
Derivados de carboxamida y urea aromaticas sustituidas como ligandos del receptor de vanilloides.
|
JP2011006408A
(ja)
|
2009-05-29 |
2011-01-13 |
Sumitomo Chemical Co Ltd |
神経栄養因子の活性が関与する疾患の治療または予防剤
|
KR20120031170A
(ko)
|
2009-06-08 |
2012-03-30 |
길리애드 사이언시즈, 인코포레이티드 |
알카노일아미노 벤즈아미드 아닐린 hdac 저해제 화합물
|
WO2010151747A1
(en)
|
2009-06-26 |
2010-12-29 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Pyrimine compounds and methods of making and using same
|
WO2011008931A2
(en)
|
2009-07-15 |
2011-01-20 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Arylpyrimidine compounds and combination therapy comprising same for treating cystic fibrosis & related disorders
|
US8415381B2
(en)
|
2009-07-30 |
2013-04-09 |
Novartis Ag |
Heteroaryl compounds and their uses
|
WO2011072275A2
(en)
|
2009-12-11 |
2011-06-16 |
Nono, Inc. |
Agents and methods for treating ischemic and other diseases
|
CA2784757A1
(en)
|
2009-12-16 |
2011-07-07 |
Novo Nordisk A/S |
Double-acylated glp-1 derivatives
|
WO2011082400A2
(en)
|
2010-01-04 |
2011-07-07 |
President And Fellows Of Harvard College |
Modulators of immunoinhibitory receptor pd-1, and methods of use thereof
|
US20130137728A1
(en)
|
2010-03-24 |
2013-05-30 |
MUSC Foundation for Research and Development |
Compositions and Methods for the Treatment of Degenerative Diseases
|
BR122017022928B1
(pt)
|
2010-04-06 |
2018-03-06 |
Nippon Soda Co., Ltd. |
Método para produção de composto heterocíclico que contém nitrogênio
|
US9133123B2
(en)
|
2010-04-23 |
2015-09-15 |
Cytokinetics, Inc. |
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
|
US8217044B2
(en)
|
2010-04-28 |
2012-07-10 |
Hoffmann-La Roche Inc. |
Spiroindolinone pyrrolidines
|
CN107021951B
(zh)
|
2010-06-30 |
2020-10-20 |
赛克里翁治疗有限公司 |
sGC刺激物
|
WO2012004217A1
(en)
|
2010-07-06 |
2012-01-12 |
Novartis Ag |
Cyclic ether compounds useful as kinase inhibitors
|
US8883839B2
(en)
|
2010-08-13 |
2014-11-11 |
Abbott Laboratories |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9051280B2
(en)
|
2010-08-13 |
2015-06-09 |
AbbVie Deutschland GmbH & Co. KG |
Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US8846743B2
(en)
|
2010-08-13 |
2014-09-30 |
Abbott Laboratories |
Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
|
WO2012024604A2
(en)
|
2010-08-20 |
2012-02-23 |
President And Fellows Of Harvard College |
High-valent palladium fluoride complexes and uses thereof
|
JP2012107001A
(ja)
|
2010-10-22 |
2012-06-07 |
Shionogi & Co Ltd |
インドールアミド化合物を含有する医薬
|
WO2012061337A1
(en)
|
2010-11-02 |
2012-05-10 |
Exelixis, Inc. |
Fgfr2 modulators
|
AU2011326241B2
(en)
|
2010-11-09 |
2016-11-17 |
Ironwood Pharmaceuticals, Inc. |
sGC stimulators
|
WO2012074050A1
(ja)
|
2010-12-01 |
2012-06-07 |
富士フイルム株式会社 |
高分子フィルム、位相差フィルム、偏光板、液晶表示装置、及び化合物
|
WO2012085789A1
(en)
|
2010-12-21 |
2012-06-28 |
Koninklijke Philips Electronics N.V. |
Agents for clearing biomolecules from circulation
|
ES2570784T3
(es)
|
2010-12-22 |
2016-05-20 |
Purdue Pharma Lp |
Piridinas sustituidas como bloqueadores de los canales de sodio
|
US20120184572A1
(en)
|
2011-01-13 |
2012-07-19 |
Metabolex, Inc. |
Aryl gpr119 agonists and uses thereof
|
CN103339110A
(zh)
|
2011-01-28 |
2013-10-02 |
诺瓦提斯公司 |
作为cdk9抑制剂的取代的杂-联芳基化合物及其用途
|
US8957066B2
(en)
*
|
2011-02-28 |
2015-02-17 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
US20140057953A1
(en)
|
2011-03-03 |
2014-02-27 |
Rolf Hartmann |
Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors
|
GB201104267D0
(en)
|
2011-03-14 |
2011-04-27 |
Cancer Rec Tech Ltd |
Pyrrolopyridineamino derivatives
|
CA2829466A1
(en)
|
2011-03-18 |
2012-09-27 |
Lupin Limited |
Benzo [b] [1,4] oxazin derivatives as calcium sensing receptor modulators
|
WO2012147890A1
(ja)
|
2011-04-27 |
2012-11-01 |
持田製薬株式会社 |
新規アゾール誘導体
|
JP6240063B2
(ja)
|
2011-04-28 |
2017-11-29 |
ザ ブロード インスティテュート, インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
WO2012154880A1
(en)
|
2011-05-09 |
2012-11-15 |
Proteostasis Therapeutics, Inc. |
Proteostasis regulators for treating cystic fibrosis and other protein misfolding diseases
|
US9309200B2
(en)
|
2011-05-12 |
2016-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
|
ES2920373T3
(es)
|
2011-05-16 |
2022-08-03 |
Tagworks Pharmaceuticals B V |
Activación de fármaco bioortogonal
|
DK2713722T3
(en)
|
2011-05-31 |
2017-07-03 |
Celgene Int Ii Sarl |
Newly known GLP-1 receptor stabilizers and modulators
|
JP2013020223A
(ja)
|
2011-06-17 |
2013-01-31 |
Fujifilm Corp |
高分子フィルム、セルロースエステルフィルム、偏光板、及び液晶表示装置
|
MX2014000964A
(es)
|
2011-07-26 |
2014-03-27 |
Gruenenthal Gmbh |
Derivados aza heterociclicos sustituidos.
|
US20130029962A1
(en)
|
2011-07-26 |
2013-01-31 |
Gruenenthal Gmbh |
Substituted Heteroaromatic Pyrazole-Containing Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
|
WO2013017480A1
(en)
|
2011-07-29 |
2013-02-07 |
Cellzome Limited |
Pyrazolo[4,3-c]pyridine derivatives as jak inhibitors
|
BR112014003112A2
(pt)
|
2011-08-12 |
2017-02-21 |
Basf Se |
composto da fórmula geral (i), métodos para preparar um composto da fórmula (i), composição agrícola ou veterinária, método para combater ou controlar pragas invertebradas, método para proteger o cultivo de plantas, método para a proteção de sementes, semente, usos de um composto e método para tratar um animal
|
EP2751086A4
(en)
|
2011-08-30 |
2015-09-16 |
Chdi Foundation Inc |
KYNURENINE-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS THEREOF AND METHOD OF USE THEREOF
|
WO2013038390A1
(en)
|
2011-09-16 |
2013-03-21 |
Novartis Ag |
N-substituted heterocyclyl carboxamides
|
US9226505B2
(en)
|
2011-09-23 |
2016-01-05 |
Bayer Intellectual Property Gmbh |
4-substituted 1-phenylpyrazole-3-carboxylic acid derivatives as agents against abiotic plant stress
|
CN103987697B
(zh)
|
2011-10-14 |
2017-04-26 |
百时美施贵宝公司 |
作为因子xia抑制剂的取代的四氢异喹啉化合物
|
WO2013059648A1
(en)
|
2011-10-21 |
2013-04-25 |
Neurotherapeutics Pharma, Inc. |
2,3,5 trisubstituted aryl and heteroaryl amino derivatives, compositions, and methods of use
|
WO2013064884A1
(en)
|
2011-10-31 |
2013-05-10 |
Purdue Pharma L.P. |
Quaternized amines as sodium channel blockers
|
US9365512B2
(en)
|
2012-02-13 |
2016-06-14 |
AbbVie Deutschland GmbH & Co. KG |
Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
|
US9321763B2
(en)
|
2012-04-04 |
2016-04-26 |
Rigel Pharmaceuticals, Inc. |
Protein kinase C inhibitors and uses thereof
|
KR101749611B1
(ko)
|
2012-04-12 |
2017-06-21 |
벌시테크 리미티드 |
유기발광다이오드용 백금(ⅱ) 착화합물
|
US20150105433A1
(en)
|
2012-04-27 |
2015-04-16 |
The Uab Research Foundation |
TREATING VIRAL INFECTIONS HAVING VIRAL RNAs TRANSLATED BY A NON-IRES MEDIATED MECHANISM
|
JP6217629B2
(ja)
|
2012-05-31 |
2017-10-25 |
住友化学株式会社 |
縮合複素環化合物
|
US9013997B2
(en)
|
2012-06-01 |
2015-04-21 |
Broadcom Corporation |
System for performing distributed data cut-through
|
BR112014031068A2
(pt)
|
2012-06-12 |
2017-06-27 |
Abbvie Inc |
derivados piridinona e piridazinona
|
CN106905297A
(zh)
|
2012-06-15 |
2017-06-30 |
加利福尼亚大学董事会 |
用于脑癌的新颖治疗剂
|
CN103508961B
(zh)
|
2012-06-26 |
2015-07-22 |
中美冠科生物技术(太仓)有限公司 |
抗肿瘤药物
|
WO2014005125A2
(en)
|
2012-06-29 |
2014-01-03 |
Biotium, Inc. |
Fluorescent compounds and uses thereof
|
JP6483610B2
(ja)
|
2012-07-18 |
2019-03-13 |
ユニバーシティ オブ ノートルダム デュ ラック |
5,5−ヘテロ芳香族抗感染症化合物
|
CN103570625A
(zh)
|
2012-07-19 |
2014-02-12 |
南京英派药业有限公司 |
N-(3-杂芳基芳基)-4-芳基芳基甲酰胺和类似物作为Hedgehog通路抑制剂及其应用
|
WO2014025808A1
(en)
|
2012-08-06 |
2014-02-13 |
The General Hospital Corporation |
Curcumin analogs
|
WO2014031928A2
(en)
|
2012-08-24 |
2014-02-27 |
Philip Jones |
Heterocyclic modulators of hif activity for treatment of disease
|
WO2014047111A1
(en)
|
2012-09-18 |
2014-03-27 |
Ironwood Pharmaceuticals, Inc. |
Sgc stimulators
|
SG11201502527UA
(en)
|
2012-10-05 |
2015-04-29 |
Rigel Pharmaceuticals Inc |
Gdf-8 inhibitors
|
US9775843B2
(en)
|
2012-10-11 |
2017-10-03 |
Grünenthal GmbH |
Treatment and/or prophylaxis of TSPO mediated diseases and/or disorders
|
JP2014101353A
(ja)
|
2012-10-26 |
2014-06-05 |
Shionogi & Co Ltd |
オキサジン誘導体を含有するアルツハイマー症治療用または予防用医薬組成物
|
US9145412B2
(en)
|
2012-11-02 |
2015-09-29 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC1 and HDAC2 inhibitors
|
WO2014074906A1
(en)
|
2012-11-09 |
2014-05-15 |
Indiana University Research And Technology Corporation |
Alternative uses for hbv assembly effectors
|
WO2014081300A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Channel protein activatable liposomes
|
WO2014081299A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Activatable liposomes
|
US20150297741A1
(en)
|
2012-11-22 |
2015-10-22 |
Tagworks Pharmaceuticals B.V. |
Bio-orthogonal drug activation
|
EP2922574B1
(en)
|
2012-11-22 |
2023-05-17 |
Tagworks Pharmaceuticals B.V. |
Chemically cleavable group
|
CA2892677A1
(en)
|
2012-12-04 |
2014-06-12 |
Rigel Pharmaceuticals, Inc. |
Protein kinase c inhibitors and uses thereof
|
CN103864754B
(zh)
|
2012-12-10 |
2016-12-21 |
中国科学院上海药物研究所 |
五元唑类杂环化合物及其制备方法、药物组合物和用途
|
WO2014164704A2
(en)
|
2013-03-11 |
2014-10-09 |
The Broad Institute, Inc. |
Compounds and compositions for the treatment of cancer
|
WO2014151936A1
(en)
|
2013-03-14 |
2014-09-25 |
The Trustees Of Columbia University In The City Of New York |
Octahydropyrrolopyrroles, their preparation and use
|
WO2014153208A1
(en)
|
2013-03-14 |
2014-09-25 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
EP2968339A4
(en)
|
2013-03-15 |
2017-02-15 |
Celgene Avilomics Research, Inc. |
Mk2 inhibitors and uses thereof
|
MX2015012803A
(es)
|
2013-03-15 |
2016-08-19 |
Epizyme Inc |
Inhibidores de la carm1 y usos de los mismos.
|
CN105308020B
(zh)
|
2013-03-20 |
2018-01-26 |
豪夫迈·罗氏有限公司 |
脲衍生物及其作为脂肪酸结合蛋白(fabp)抑制剂的用途
|
WO2014181287A1
(en)
|
2013-05-09 |
2014-11-13 |
Piramal Enterprises Limited |
Heterocyclyl compounds and uses thereof
|
CN104163791B
(zh)
|
2013-05-20 |
2017-05-03 |
湖南化工研究院 |
N‑吡啶(杂)芳酰胺类化合物及其制备方法与应用
|
CN104163792B
(zh)
|
2013-05-20 |
2017-04-12 |
湖南化工研究院 |
N‑吡啶酰胺类化合物及其制备方法与应用
|
CA2911326A1
(en)
|
2013-05-24 |
2014-11-27 |
The California Institute For Biomedical Research |
Compounds for treatment of drug resistant and persistent tuberculosis
|
JP6640716B2
(ja)
|
2013-05-30 |
2020-02-05 |
ワシントン・ユニバーシティWashington University |
細菌感染症を治療するための化合物及び方法
|
CN104232076B
(zh)
|
2013-06-10 |
2019-01-15 |
代表亚利桑那大学的亚利桑那校董会 |
具有改进的发射光谱的磷光四齿金属络合物
|
GB2515785A
(en)
|
2013-07-03 |
2015-01-07 |
Redx Pharma Ltd |
Compounds
|
GB2516303A
(en)
|
2013-07-18 |
2015-01-21 |
Redx Pharma Ltd |
Compounds
|
US9359330B2
(en)
|
2013-08-26 |
2016-06-07 |
Purdue Pharma L.P. |
Substituted piperidines as sodium channel blockers
|
WO2015031725A1
(en)
|
2013-08-30 |
2015-03-05 |
President And Fellows Of Harvard College |
Transition metal-catalyzed imidation of arenes
|
EA201690230A1
(ru)
|
2013-09-06 |
2016-07-29 |
Инсепшн 2, Инк. |
Соединения триазолона и их применения
|
US9663508B2
(en)
|
2013-10-01 |
2017-05-30 |
Amgen Inc. |
Biaryl acyl-sulfonamide compounds as sodium channel inhibitors
|
KR102307387B1
(ko)
|
2013-10-08 |
2021-09-30 |
큉-빈 루 |
표적화된 화학요법에 사용하기 위한 비백금기반 항암 화합물
|
PT3060550T
(pt)
|
2013-10-21 |
2019-08-27 |
Merck Patent Gmbh |
Compostos de heteroarilo como inibidores de btk e utilizações dos mesmos
|
CA2931097A1
(en)
|
2013-11-19 |
2015-05-28 |
Vanderbilt University |
Substituted imidazopyridine and triazolopyridine compounds as negative allosteric modulators of mglur5
|
CN103601718A
(zh)
|
2013-12-05 |
2014-02-26 |
江西天人生态股份有限公司 |
一类基于鱼泥丁受体的邻甲酰氨基苯甲酰胺衍生物及其制备方法和用途
|
WO2015110999A1
(en)
|
2014-01-24 |
2015-07-30 |
Piramal Enterprises Limited |
Ezh2 inhibitors and uses thereof
|
CN103804312B
(zh)
|
2014-02-17 |
2016-04-20 |
四川百利药业有限责任公司 |
一类氮杂环化合物及其制备方法和用途
|
WO2015142903A2
(en)
|
2014-03-17 |
2015-09-24 |
Genentech, Inc. |
Method of controlling lactate production with piperdine-dione derivatives
|
US9533982B2
(en)
|
2014-03-20 |
2017-01-03 |
Vanderbilt University |
Substituted bicyclic heteroaryl carboxamide analogs as mGluR5 negative allosteric modulators
|
GB201405002D0
(en)
|
2014-03-20 |
2014-05-07 |
Isis Innovation |
Fluorination method
|
US11691997B2
(en)
|
2014-04-09 |
2023-07-04 |
Lumiphore, Inc. |
Macrocycles
|
EP3140298A1
(en)
|
2014-05-07 |
2017-03-15 |
Pfizer Inc. |
Tropomyosin-related kinase inhibitors
|
CN106535891A
(zh)
*
|
2014-06-02 |
2017-03-22 |
Chdi基金会股份有限公司 |
组蛋白脱乙酰酶抑制剂及其组合物和使用方法
|
US20170349540A1
(en)
|
2014-07-28 |
2017-12-07 |
The General Hospital Corporation |
Histone deacetylase inhibitors
|
EP3177622A1
(en)
|
2014-08-04 |
2017-06-14 |
Fundacion para la Investigacion Medica Aplicada |
Novel compounds for use in cognition improvement
|
US9701685B2
(en)
|
2014-08-18 |
2017-07-11 |
Hudson Biopharma Inc. |
Spiropyrrolidines as MDM2 inhibitors
|
GB201416513D0
(en)
|
2014-09-18 |
2014-11-05 |
Astex Therapeutics Ltd And Cancer Res Technology Ltd |
Pharmaceutical compounds
|
US9550778B2
(en)
|
2014-10-03 |
2017-01-24 |
Vanderbilt University |
Substituted 6-aryl-imidazopyridine and 6-aryl-triazolopyridine carboxamide analogs as negative allosteric modulators of mGluR5
|
WO2016057779A2
(en)
|
2014-10-08 |
2016-04-14 |
Acetylon Pharmaceuticals, Inc. |
Induction of gata2 by hdac1 and hdac2 inhibitors
|
WO2016058544A1
(en)
|
2014-10-16 |
2016-04-21 |
Syros Pharmaceuticals, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
CN117024502A
(zh)
|
2014-10-16 |
2023-11-10 |
萨奇治疗股份有限公司 |
靶向cns障碍的组合物和方法
|
WO2016100711A1
(en)
|
2014-12-18 |
2016-06-23 |
The Broad Institute, Inc. |
Modulators of hepatic lipoprotein metabolism
|
CN105777632A
(zh)
|
2015-01-09 |
2016-07-20 |
成都贝斯凯瑞生物科技有限公司 |
芳环并氮杂环衍生物及其应用
|
ES2928084T3
(es)
|
2015-02-20 |
2022-11-15 |
Rigel Pharmaceuticals Inc |
Inhibidores de GDF-8
|
EP4212532A3
(en)
|
2015-04-30 |
2023-09-27 |
Memorial Sloan Kettering Cancer Center |
Mitragynine analogs and uses thereof
|
CN106083823A
(zh)
|
2015-04-30 |
2016-11-09 |
中国科学院上海药物研究所 |
一类具有激酶抑制活性的化合物、制备方法和用途
|
WO2016183266A1
(en)
|
2015-05-13 |
2016-11-17 |
Enanta Pharmaceuticals, Inc. |
Ehpatitis b antiviral agents
|
LT3319959T
(lt)
|
2015-07-06 |
2021-12-27 |
Alkermes, Inc. |
Histono deacetilazės hetero-halogeno inhibitoriai
|
WO2017007755A1
(en)
*
|
2015-07-06 |
2017-01-12 |
Rodin Therapeutics, Inc. |
Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
|
WO2017027984A1
(en)
|
2015-08-20 |
2017-02-23 |
Simon Fraser University |
Compounds and methods for treatment of cancer by inhibiting atg4b and blocking autophagy
|
US10980755B2
(en)
|
2015-09-10 |
2021-04-20 |
The Regents Of The University Of California |
LRH-1 modulators
|
EP3362436B1
(en)
|
2015-09-14 |
2021-06-30 |
Universiteit Antwerpen |
Process for the catalytic directed cleavage of amide-containing compounds
|
WO2017075694A1
(en)
|
2015-11-04 |
2017-05-11 |
Simon Fraser University |
Antibiotic compounds, pharmaceutical formulations thereof and methods and uses therefor
|
TW202246215A
(zh)
|
2015-12-18 |
2022-12-01 |
美商亞德利克斯公司 |
作為非全身tgr5促效劑之經取代之4-苯基吡啶化合物
|
HUE049228T2
(hu)
|
2016-02-23 |
2020-09-28 |
Taiho Pharmaceutical Co Ltd |
Új kondenzált pirimidin vegyület vagy annak sója
|
US11179710B2
(en)
|
2016-03-09 |
2021-11-23 |
President And Fellows Of Harvard College |
Direct palladium-catalyzed aromatic fluorination
|
TWI794171B
(zh)
|
2016-05-11 |
2023-03-01 |
美商滬亞生物國際有限公司 |
Hdac抑制劑與pd-l1抑制劑之組合治療
|
EP3544969A1
(en)
|
2016-11-23 |
2019-10-02 |
Regenacy Pharmaceuticals, LLC |
Piperazine derivatives as selective hdac1,2 inhibitors
|
SG11201906164RA
(en)
|
2017-01-11 |
2019-08-27 |
Rodin Therapeutics Inc |
Bicyclic inhibitors of histone deacetylase
|
CN106946890A
(zh)
|
2017-04-26 |
2017-07-14 |
中国药科大学 |
吡啶类irak4抑制剂、其制备方法及应用
|
JP7152471B2
(ja)
|
2017-08-07 |
2022-10-12 |
ロダン・セラピューティクス,インコーポレーテッド |
ヒストン脱アセチル化酵素の二環阻害剤
|
CN112424184A
(zh)
|
2018-07-13 |
2021-02-26 |
奥克梅斯公司 |
组蛋白脱乙酰酶双环抑制剂
|
SG11202012918PA
(en)
|
2018-07-13 |
2021-02-25 |
Alkermes Inc |
Bicyclic inhibitors of histone deacetylase
|